Norris Medicines appoints Iqubal Ismail Patel as CFO and KMP
Norris Medicines Limited appointed Iqubal Ismail Patel as CFO and KMP effective July 30, 2026. The Board approved the move following recommendations from the Audit and Nomination Committees. Patel brings over 11 years of internal experience in finance and strategic initiatives to the position.
*this image is generated using AI for illustrative purposes only.
Norris Medicines Limited appointed Iqubal Ismail Patel as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective July 30, 2026. The Board of Directors approved the appointment during a meeting held on July 30, 2026, acting on recommendations from both the Audit Committee and the Nomination and Remuneration Committee. This leadership change strengthens the company’s financial oversight with an insider who possesses deep institutional knowledge.
The appointment was made pursuant to Section 203 of the Companies Act, 2013 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 5:00 PM and concluded at 5:30 PM on July 30, 2026. Norris Medicines Limited submitted the disclosure to BSE Limited, citing compliance with SEBI Circular Ref. No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Appointment Details
Patel’s term of appointment is subject to terms and conditions, including remuneration, to be mutually agreed upon between him and the Board of Directors. He is not related to any existing Directors or Key Managerial Personnel of the company. The filing confirms that Patel is not debarred from holding office by virtue of any SEBI Order or other authority, nor is he disqualified under Section 164 of the Companies Act, 2013.
| Detail | Information |
|---|---|
| Name | Iqubal Ismail Patel |
| Designation | Chief Financial Officer and KMP |
| Effective Date | July 30, 2026 |
| Term | As mutually agreed between Patel and the Board |
| Relationship Disclosure | Not related to any Directors or KMPs |
Candidate Profile
Iqubal Ismail Patel holds a Graduate degree and has been associated with Norris Medicines Limited for more than 11 years. His experience spans finance, accounts, taxation, budgeting, financial planning, and corporate management. According to the filing, he has played a significant role in the company’s financial operations and strategic initiatives in the past. His long-standing association with the organization suggests continuity in financial strategy rather than a shift in direction.
The appointment ensures that the CFO role is filled by a candidate familiar with the company’s operational framework and regulatory history. With over a decade of internal experience, Patel is positioned to manage financial planning and corporate governance matters without a steep learning curve regarding the company’s specific business model and risk profile.
Historical Stock Returns for Norris Medicines
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.05% | -3.77% | +9.29% | +9.78% | -9.74% | +72.33% |
How might Iqubal Ismail Patel's 11 years of internal experience influence Norris Medicines' upcoming financial strategies and capital allocation decisions?
What specific financial targets or restructuring initiatives is the Board likely to prioritize under Patel's new CFO leadership in the next fiscal year?
Could this appointment signal a shift towards more aggressive cost management or expansion plans given Patel's background in budgeting and corporate management?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
